Combination therapy (CT) with a mandibular advancement device (MAD) and positive airway pressure (PAP) has been advocated for patients for whom neither MAD nor PAP alone provides an efficacious and tolerated therapy. This article reviews the small and limited, but growing body of evidence in support of CT and highlights details in its implementation. In most studies, CT was found to be preferred by many, but not all PAP-intolerant patients. CT can be more efficacious than either MAD or PAP alone.
Keyphrases
- obstructive sleep apnea
- end stage renal disease
- positive airway pressure
- computed tomography
- combination therapy
- image quality
- ejection fraction
- newly diagnosed
- chronic kidney disease
- dual energy
- contrast enhanced
- healthcare
- primary care
- prognostic factors
- peritoneal dialysis
- magnetic resonance imaging
- stem cells
- randomized controlled trial
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- chemotherapy induced